XTRA:SRT3Life Sciences
Assessing Sartorius (XTRA:SRT3) Valuation As High P/E Contrasts With Discounted Cash Flow Estimate
How Sartorius Stock Has Been Performing
Sartorius (XTRA:SRT3) has seen mixed share performance, with the stock roughly flat over the past week, modestly positive over the past month, but showing negative returns over the past 3 months, year to date, and the past year.
Over a longer horizon, Sartorius also records negative total returns across the past 3 years and past 5 years. This provides a sense of how recent trading levels compare with earlier periods for the stock.
See our latest...